Global PDE Inhibitors Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global PDE Inhibitors Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for PDE Inhibitors by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for PDE Inhibitors by Country/Region, 2017, 2022 & 2028

2.2 PDE Inhibitors Segment by Type

2.2.1 PDE5

2.2.2 PDE4

2.2.3 Viagra

2.2.4 Cialis

2.2.5 Levitra

2.2.6 Others

2.3 PDE Inhibitors Sales by Type

2.3.1 Global PDE Inhibitors Sales Market Share by Type (2017-2022)

2.3.2 Global PDE Inhibitors Revenue and Market Share by Type (2017-2022)

2.3.3 Global PDE Inhibitors Sale Price by Type (2017-2022)

2.4 PDE Inhibitors Segment by Application

2.4.1 Genitourinary

2.4.2 Cardiovascular Diseases

2.4.3 Dermatological Disorders

2.4.4 Respiratory Diseases

2.4.5 Schizophrenia

2.4.6 Alzheimer’S Disease

2.4.7 Huntington’S Disease

2.4.8 Others

2.5 PDE Inhibitors Sales by Application

2.5.1 Global PDE Inhibitors Sale Market Share by Application (2017-2022)

2.5.2 Global PDE Inhibitors Revenue and Market Share by Application (2017-2022)

2.5.3 Global PDE Inhibitors Sale Price by Application (2017-2022)

3 Global PDE Inhibitors by Company

3.1 Global PDE Inhibitors Breakdown Data by Company

3.1.1 Global PDE Inhibitors Annual Sales by Company (2020-2022)

3.1.2 Global PDE Inhibitors Sales Market Share by Company (2020-2022)

3.2 Global PDE Inhibitors Annual Revenue by Company (2020-2022)

3.2.1 Global PDE Inhibitors Revenue by Company (2020-2022)

3.2.2 Global PDE Inhibitors Revenue Market Share by Company (2020-2022)

3.3 Global PDE Inhibitors Sale Price by Company

3.4 Key Manufacturers PDE Inhibitors Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers PDE Inhibitors Product Location Distribution

3.4.2 Players PDE Inhibitors Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for PDE Inhibitors by Geographic Region

4.1 World Historic PDE Inhibitors Market Size by Geographic Region (2017-2022)

4.1.1 Global PDE Inhibitors Annual Sales by Geographic Region (2017-2022)

4.1.2 Global PDE Inhibitors Annual Revenue by Geographic Region

4.2 World Historic PDE Inhibitors Market Size by Country/Region (2017-2022)

4.2.1 Global PDE Inhibitors Annual Sales by Country/Region (2017-2022)

4.2.2 Global PDE Inhibitors Annual Revenue by Country/Region

4.3 Americas PDE Inhibitors Sales Growth

4.4 APAC PDE Inhibitors Sales Growth

4.5 Europe PDE Inhibitors Sales Growth

4.6 Middle East & Africa PDE Inhibitors Sales Growth

5 Americas

5.1 Americas PDE Inhibitors Sales by Country

5.1.1 Americas PDE Inhibitors Sales by Country (2017-2022)

5.1.2 Americas PDE Inhibitors Revenue by Country (2017-2022)

5.2 Americas PDE Inhibitors Sales by Type

5.3 Americas PDE Inhibitors Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC PDE Inhibitors Sales by Region

6.1.1 APAC PDE Inhibitors Sales by Region (2017-2022)

6.1.2 APAC PDE Inhibitors Revenue by Region (2017-2022)

6.2 APAC PDE Inhibitors Sales by Type

6.3 APAC PDE Inhibitors Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe PDE Inhibitors by Country

7.1.1 Europe PDE Inhibitors Sales by Country (2017-2022)

7.1.2 Europe PDE Inhibitors Revenue by Country (2017-2022)

7.2 Europe PDE Inhibitors Sales by Type

7.3 Europe PDE Inhibitors Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa PDE Inhibitors by Country

8.1.1 Middle East & Africa PDE Inhibitors Sales by Country (2017-2022)

8.1.2 Middle East & Africa PDE Inhibitors Revenue by Country (2017-2022)

8.2 Middle East & Africa PDE Inhibitors Sales by Type

8.3 Middle East & Africa PDE Inhibitors Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of PDE Inhibitors

10.3 Manufacturing Process Analysis of PDE Inhibitors

10.4 Industry Chain Structure of PDE Inhibitors

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 PDE Inhibitors Distributors

11.3 PDE Inhibitors Customer

12 World Forecast Review for PDE Inhibitors by Geographic Region

12.1 Global PDE Inhibitors Market Size Forecast by Region

12.1.1 Global PDE Inhibitors Forecast by Region (2023-2028)

12.1.2 Global PDE Inhibitors Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global PDE Inhibitors Forecast by Type

12.7 Global PDE Inhibitors Forecast by Application

13 Key Players Analysis

13.1 Hanmi Science Holding

13.1.1 Hanmi Science Holding Company Information

13.1.2 Hanmi Science Holding PDE Inhibitors Product Offered

13.1.3 Hanmi Science Holding PDE Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Hanmi Science Holding Main Business Overview

13.1.5 Hanmi Science Holding Latest Developments

13.2 Boehringer Ingelheim

13.2.1 Boehringer Ingelheim Company Information

13.2.2 Boehringer Ingelheim PDE Inhibitors Product Offered

13.2.3 Boehringer Ingelheim PDE Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Boehringer Ingelheim Main Business Overview

13.2.5 Boehringer Ingelheim Latest Developments

13.3 Takeda Pharmaceuticals

13.3.1 Takeda Pharmaceuticals Company Information

13.3.2 Takeda Pharmaceuticals PDE Inhibitors Product Offered

13.3.3 Takeda Pharmaceuticals PDE Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Takeda Pharmaceuticals Main Business Overview

13.3.5 Takeda Pharmaceuticals Latest Developments

13.4 AstraZeneca

13.4.1 AstraZeneca Company Information

13.4.2 AstraZeneca PDE Inhibitors Product Offered

13.4.3 AstraZeneca PDE Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 AstraZeneca Main Business Overview

13.4.5 AstraZeneca Latest Developments

13.5 Bayer

13.5.1 Bayer Company Information

13.5.2 Bayer PDE Inhibitors Product Offered

13.5.3 Bayer PDE Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Bayer Main Business Overview

13.5.5 Bayer Latest Developments

13.6 Celgene

13.6.1 Celgene Company Information

13.6.2 Celgene PDE Inhibitors Product Offered

13.6.3 Celgene PDE Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Celgene Main Business Overview

13.6.5 Celgene Latest Developments

13.7 Eli Lilly

13.7.1 Eli Lilly Company Information

13.7.2 Eli Lilly PDE Inhibitors Product Offered

13.7.3 Eli Lilly PDE Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Eli Lilly Main Business Overview

13.7.5 Eli Lilly Latest Developments

13.8 Pfizer

13.8.1 Pfizer Company Information

13.8.2 Pfizer PDE Inhibitors Product Offered

13.8.3 Pfizer PDE Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Pfizer Main Business Overview

13.8.5 Pfizer Latest Developments

13.9 BioCrea

13.9.1 BioCrea Company Information

13.9.2 BioCrea PDE Inhibitors Product Offered

13.9.3 BioCrea PDE Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 BioCrea Main Business Overview

13.9.5 BioCrea Latest Developments

13.10 Dart NeuroScience

13.10.1 Dart NeuroScience Company Information

13.10.2 Dart NeuroScience PDE Inhibitors Product Offered

13.10.3 Dart NeuroScience PDE Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Dart NeuroScience Main Business Overview

13.10.5 Dart NeuroScience Latest Developments

13.11 Carinopharm

13.11.1 Carinopharm Company Information

13.11.2 Carinopharm PDE Inhibitors Product Offered

13.11.3 Carinopharm PDE Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Carinopharm Main Business Overview

13.11.5 Carinopharm Latest Developments

13.12 CTC Bio

13.12.1 CTC Bio Company Information

13.12.2 CTC Bio PDE Inhibitors Product Offered

13.12.3 CTC Bio PDE Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 CTC Bio Main Business Overview

13.12.5 CTC Bio Latest Developments

13.13 FORUM Pharmaceuticals

13.13.1 FORUM Pharmaceuticals Company Information

13.13.2 FORUM Pharmaceuticals PDE Inhibitors Product Offered

13.13.3 FORUM Pharmaceuticals PDE Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 FORUM Pharmaceuticals Main Business Overview

13.13.5 FORUM Pharmaceuticals Latest Developments

13.14 Intra-Cellular Therapies

13.14.1 Intra-Cellular Therapies Company Information

13.14.2 Intra-Cellular Therapies PDE Inhibitors Product Offered

13.14.3 Intra-Cellular Therapies PDE Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Intra-Cellular Therapies Main Business Overview

13.14.5 Intra-Cellular Therapies Latest Developments

13.15 Omeros Corporation

13.15.1 Omeros Corporation Company Information

13.15.2 Omeros Corporation PDE Inhibitors Product Offered

13.15.3 Omeros Corporation PDE Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Omeros Corporation Main Business Overview

13.15.5 Omeros Corporation Latest Developments

13.16 Medimetriks Pharmaceuticals

13.16.1 Medimetriks Pharmaceuticals Company Information

13.16.2 Medimetriks Pharmaceuticals PDE Inhibitors Product Offered

13.16.3 Medimetriks Pharmaceuticals PDE Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Medimetriks Pharmaceuticals Main Business Overview

13.16.5 Medimetriks Pharmaceuticals Latest Developments

13.17 NuSirt Biopharma

13.17.1 NuSirt Biopharma Company Information

13.17.2 NuSirt Biopharma PDE Inhibitors Product Offered

13.17.3 NuSirt Biopharma PDE Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 NuSirt Biopharma Main Business Overview

13.17.5 NuSirt Biopharma Latest Developments

13.18 Palobiopharma

13.18.1 Palobiopharma Company Information

13.18.2 Palobiopharma PDE Inhibitors Product Offered

13.18.3 Palobiopharma PDE Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)

13.18.4 Palobiopharma Main Business Overview

13.18.5 Palobiopharma Latest Developments

13.19 Roivant Sciences

13.19.1 Roivant Sciences Company Information

13.19.2 Roivant Sciences PDE Inhibitors Product Offered

13.19.3 Roivant Sciences PDE Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)

13.19.4 Roivant Sciences Main Business Overview

13.19.5 Roivant Sciences Latest Developments

13.20 Sagene Pharmaceuticals

13.20.1 Sagene Pharmaceuticals Company Information

13.20.2 Sagene Pharmaceuticals PDE Inhibitors Product Offered

13.20.3 Sagene Pharmaceuticals PDE Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)

13.20.4 Sagene Pharmaceuticals Main Business Overview

13.20.5 Sagene Pharmaceuticals Latest Developments

13.21 Tetra Discovery Partners

13.21.1 Tetra Discovery Partners Company Information

13.21.2 Tetra Discovery Partners PDE Inhibitors Product Offered

13.21.3 Tetra Discovery Partners PDE Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)

13.21.4 Tetra Discovery Partners Main Business Overview

13.21.5 Tetra Discovery Partners Latest Developments

13.22 Tritech Biopharm

13.22.1 Tritech Biopharm Company Information

13.22.2 Tritech Biopharm PDE Inhibitors Product Offered

13.22.3 Tritech Biopharm PDE Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)

13.22.4 Tritech Biopharm Main Business Overview

13.22.5 Tritech Biopharm Latest Developments

13.23 Otsuka

13.23.1 Otsuka Company Information

13.23.2 Otsuka PDE Inhibitors Product Offered

13.23.3 Otsuka PDE Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)

13.23.4 Otsuka Main Business Overview

13.23.5 Otsuka Latest Developments

13.24 Chiesi Farmaceutici

13.24.1 Chiesi Farmaceutici Company Information

13.24.2 Chiesi Farmaceutici PDE Inhibitors Product Offered

13.24.3 Chiesi Farmaceutici PDE Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)

13.24.4 Chiesi Farmaceutici Main Business Overview

13.24.5 Chiesi Farmaceutici Latest Developments

13.25 Verona Pharma

13.25.1 Verona Pharma Company Information

13.25.2 Verona Pharma PDE Inhibitors Product Offered

13.25.3 Verona Pharma PDE Inhibitors Sales, Revenue, Price and Gross Margin (2020-2022)

13.25.4 Verona Pharma Main Business Overview

13.25.5 Verona Pharma Latest Developments

14 Research Findings and Conclusion

Table 1. PDE Inhibitors Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. PDE Inhibitors Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of PDE5

Table 4. Major Players of PDE4

Table 5. Major Players of Viagra

Table 6. Major Players of Cialis

Table 7. Major Players of Levitra

Table 8. Major Players of Others

Table 9. Global PDE Inhibitors Sales by Type (2017-2022) & (K Units)

Table 10. Global PDE Inhibitors Sales Market Share by Type (2017-2022)

Table 11. Global PDE Inhibitors Revenue by Type (2017-2022) & ($ million)

Table 12. Global PDE Inhibitors Revenue Market Share by Type (2017-2022)

Table 13. Global PDE Inhibitors Sale Price by Type (2017-2022) & (USD/Unit)

Table 14. Global PDE Inhibitors Sales by Application (2017-2022) & (K Units)

Table 15. Global PDE Inhibitors Sales Market Share by Application (2017-2022)

Table 16. Global PDE Inhibitors Revenue by Application (2017-2022)

Table 17. Global PDE Inhibitors Revenue Market Share by Application (2017-2022)

Table 18. Global PDE Inhibitors Sale Price by Application (2017-2022) & (USD/Unit)

Table 19. Global PDE Inhibitors Sales by Company (2020-2022) & (K Units)

Table 20. Global PDE Inhibitors Sales Market Share by Company (2020-2022)

Table 21. Global PDE Inhibitors Revenue by Company (2020-2022) ($ Millions)

Table 22. Global PDE Inhibitors Revenue Market Share by Company (2020-2022)

Table 23. Global PDE Inhibitors Sale Price by Company (2020-2022) & (USD/Unit)

Table 24. Key Manufacturers PDE Inhibitors Producing Area Distribution and Sales Area

Table 25. Players PDE Inhibitors Products Offered

Table 26. PDE Inhibitors Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 27. New Products and Potential Entrants

Table 28. Mergers & Acquisitions, Expansion

Table 29. Global PDE Inhibitors Sales by Geographic Region (2017-2022) & (K Units)

Table 30. Global PDE Inhibitors Sales Market Share Geographic Region (2017-2022)

Table 31. Global PDE Inhibitors Revenue by Geographic Region (2017-2022) & ($ millions)

Table 32. Global PDE Inhibitors Revenue Market Share by Geographic Region (2017-2022)

Table 33. Global PDE Inhibitors Sales by Country/Region (2017-2022) & (K Units)

Table 34. Global PDE Inhibitors Sales Market Share by Country/Region (2017-2022)

Table 35. Global PDE Inhibitors Revenue by Country/Region (2017-2022) & ($ millions)

Table 36. Global PDE Inhibitors Revenue Market Share by Country/Region (2017-2022)

Table 37. Americas PDE Inhibitors Sales by Country (2017-2022) & (K Units)

Table 38. Americas PDE Inhibitors Sales Market Share by Country (2017-2022)

Table 39. Americas PDE Inhibitors Revenue by Country (2017-2022) & ($ Millions)

Table 40. Americas PDE Inhibitors Revenue Market Share by Country (2017-2022)

Table 41. Americas PDE Inhibitors Sales by Type (2017-2022) & (K Units)

Table 42. Americas PDE Inhibitors Sales Market Share by Type (2017-2022)

Table 43. Americas PDE Inhibitors Sales by Application (2017-2022) & (K Units)

Table 44. Americas PDE Inhibitors Sales Market Share by Application (2017-2022)

Table 45. APAC PDE Inhibitors Sales by Region (2017-2022) & (K Units)

Table 46. APAC PDE Inhibitors Sales Market Share by Region (2017-2022)

Table 47. APAC PDE Inhibitors Revenue by Region (2017-2022) & ($ Millions)

Table 48. APAC PDE Inhibitors Revenue Market Share by Region (2017-2022)

Table 49. APAC PDE Inhibitors Sales by Type (2017-2022) & (K Units)

Table 50. APAC PDE Inhibitors Sales Market Share by Type (2017-2022)

Table 51. APAC PDE Inhibitors Sales by Application (2017-2022) & (K Units)

Table 52. APAC PDE Inhibitors Sales Market Share by Application (2017-2022)

Table 53. Europe PDE Inhibitors Sales by Country (2017-2022) & (K Units)

Table 54. Europe PDE Inhibitors Sales Market Share by Country (2017-2022)

Table 55. Europe PDE Inhibitors Revenue by Country (2017-2022) & ($ Millions)

Table 56. Europe PDE Inhibitors Revenue Market Share by Country (2017-2022)

Table 57. Europe PDE Inhibitors Sales by Type (2017-2022) & (K Units)

Table 58. Europe PDE Inhibitors Sales Market Share by Type (2017-2022)

Table 59. Europe PDE Inhibitors Sales by Application (2017-2022) & (K Units)

Table 60. Europe PDE Inhibitors Sales Market Share by Application (2017-2022)

Table 61. Middle East & Africa PDE Inhibitors Sales by Country (2017-2022) & (K Units)

Table 62. Middle East & Africa PDE Inhibitors Sales Market Share by Country (2017-2022)

Table 63. Middle East & Africa PDE Inhibitors Revenue by Country (2017-2022) & ($ Millions)

Table 64. Middle East & Africa PDE Inhibitors Revenue Market Share by Country (2017-2022)

Table 65. Middle East & Africa PDE Inhibitors Sales by Type (2017-2022) & (K Units)

Table 66. Middle East & Africa PDE Inhibitors Sales Market Share by Type (2017-2022)

Table 67. Middle East & Africa PDE Inhibitors Sales by Application (2017-2022) & (K Units)

Table 68. Middle East & Africa PDE Inhibitors Sales Market Share by Application (2017-2022)

Table 69. Key Market Drivers & Growth Opportunities of PDE Inhibitors

Table 70. Key Market Challenges & Risks of PDE Inhibitors

Table 71. Key Industry Trends of PDE Inhibitors

Table 72. PDE Inhibitors Raw Material

Table 73. Key Suppliers of Raw Materials

Table 74. PDE Inhibitors Distributors List

Table 75. PDE Inhibitors Customer List

Table 76. Global PDE Inhibitors Sales Forecast by Region (2023-2028) & (K Units)

Table 77. Global PDE Inhibitors Sales Market Forecast by Region

Table 78. Global PDE Inhibitors Revenue Forecast by Region (2023-2028) & ($ millions)

Table 79. Global PDE Inhibitors Revenue Market Share Forecast by Region (2023-2028)

Table 80. Americas PDE Inhibitors Sales Forecast by Country (2023-2028) & (K Units)

Table 81. Americas PDE Inhibitors Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. APAC PDE Inhibitors Sales Forecast by Region (2023-2028) & (K Units)

Table 83. APAC PDE Inhibitors Revenue Forecast by Region (2023-2028) & ($ millions)

Table 84. Europe PDE Inhibitors Sales Forecast by Country (2023-2028) & (K Units)

Table 85. Europe PDE Inhibitors Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Middle East & Africa PDE Inhibitors Sales Forecast by Country (2023-2028) & (K Units)

Table 87. Middle East & Africa PDE Inhibitors Revenue Forecast by Country (2023-2028) & ($ millions)

Table 88. Global PDE Inhibitors Sales Forecast by Type (2023-2028) & (K Units)

Table 89. Global PDE Inhibitors Sales Market Share Forecast by Type (2023-2028)

Table 90. Global PDE Inhibitors Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 91. Global PDE Inhibitors Revenue Market Share Forecast by Type (2023-2028)

Table 92. Global PDE Inhibitors Sales Forecast by Application (2023-2028) & (K Units)

Table 93. Global PDE Inhibitors Sales Market Share Forecast by Application (2023-2028)

Table 94. Global PDE Inhibitors Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 95. Global PDE Inhibitors Revenue Market Share Forecast by Application (2023-2028)

Table 96. Hanmi Science Holding Basic Information, PDE Inhibitors Manufacturing Base, Sales Area and Its Competitors

Table 97. Hanmi Science Holding PDE Inhibitors Product Offered

Table 98. Hanmi Science Holding PDE Inhibitors Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 99. Hanmi Science Holding Main Business

Table 100. Hanmi Science Holding Latest Developments

Table 101. Boehringer Ingelheim Basic Information, PDE Inhibitors Manufacturing Base, Sales Area and Its Competitors

Table 102. Boehringer Ingelheim PDE Inhibitors Product Offered

Table 103. Boehringer Ingelheim PDE Inhibitors Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 104. Boehringer Ingelheim Main Business

Table 105. Boehringer Ingelheim Latest Developments

Table 106. Takeda Pharmaceuticals Basic Information, PDE Inhibitors Manufacturing Base, Sales Area and Its Competitors

Table 107. Takeda Pharmaceuticals PDE Inhibitors Product Offered

Table 108. Takeda Pharmaceuticals PDE Inhibitors Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 109. Takeda Pharmaceuticals Main Business

Table 110. Takeda Pharmaceuticals Latest Developments

Table 111. AstraZeneca Basic Information, PDE Inhibitors Manufacturing Base, Sales Area and Its Competitors

Table 112. AstraZeneca PDE Inhibitors Product Offered

Table 113. AstraZeneca PDE Inhibitors Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 114. AstraZeneca Main Business

Table 115. AstraZeneca Latest Developments

Table 116. Bayer Basic Information, PDE Inhibitors Manufacturing Base, Sales Area and Its Competitors

Table 117. Bayer PDE Inhibitors Product Offered

Table 118. Bayer PDE Inhibitors Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 119. Bayer Main Business

Table 120. Bayer Latest Developments

Table 121. Celgene Basic Information, PDE Inhibitors Manufacturing Base, Sales Area and Its Competitors

Table 122. Celgene PDE Inhibitors Product Offered

Table 123. Celgene PDE Inhibitors Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 124. Celgene Main Business

Table 125. Celgene Latest Developments

Table 126. Eli Lilly Basic Information, PDE Inhibitors Manufacturing Base, Sales Area and Its Competitors

Table 127. Eli Lilly PDE Inhibitors Product Offered

Table 128. Eli Lilly PDE Inhibitors Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 129. Eli Lilly Main Business

Table 130. Eli Lilly Latest Developments

Table 131. Pfizer Basic Information, PDE Inhibitors Manufacturing Base, Sales Area and Its Competitors

Table 132. Pfizer PDE Inhibitors Product Offered

Table 133. Pfizer PDE Inhibitors Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 134. Pfizer Main Business

Table 135. Pfizer Latest Developments

Table 136. BioCrea Basic Information, PDE Inhibitors Manufacturing Base, Sales Area and Its Competitors

Table 137. BioCrea PDE Inhibitors Product Offered

Table 138. BioCrea PDE Inhibitors Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 139. BioCrea Main Business

Table 140. BioCrea Latest Developments

Table 141. Dart NeuroScience Basic Information, PDE Inhibitors Manufacturing Base, Sales Area and Its Competitors

Table 142. Dart NeuroScience PDE Inhibitors Product Offered

Table 143. Dart NeuroScience PDE Inhibitors Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 144. Dart NeuroScience Main Business

Table 145. Dart NeuroScience Latest Developments

Table 146. Carinopharm Basic Information, PDE Inhibitors Manufacturing Base, Sales Area and Its Competitors

Table 147. Carinopharm PDE Inhibitors Product Offered

Table 148. Carinopharm PDE Inhibitors Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 149. Carinopharm Main Business

Table 150. Carinopharm Latest Developments

Table 151. CTC Bio Basic Information, PDE Inhibitors Manufacturing Base, Sales Area and Its Competitors

Table 152. CTC Bio PDE Inhibitors Product Offered

Table 153. CTC Bio PDE Inhibitors Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 154. CTC Bio Main Business

Table 155. CTC Bio Latest Developments

Table 156. FORUM Pharmaceuticals Basic Information, PDE Inhibitors Manufacturing Base, Sales Area and Its Competitors

Table 157. FORUM Pharmaceuticals PDE Inhibitors Product Offered

Table 158. FORUM Pharmaceuticals PDE Inhibitors Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 159. FORUM Pharmaceuticals Main Business

Table 160. FORUM Pharmaceuticals Latest Developments

Table 161. Intra-Cellular Therapies Basic Information, PDE Inhibitors Manufacturing Base, Sales Area and Its Competitors

Table 162. Intra-Cellular Therapies PDE Inhibitors Product Offered

Table 163. Intra-Cellular Therapies PDE Inhibitors Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 164. Intra-Cellular Therapies Main Business

Table 165. Intra-Cellular Therapies Latest Developments

Table 166. Omeros Corporation Basic Information, PDE Inhibitors Manufacturing Base, Sales Area and Its Competitors

Table 167. Omeros Corporation PDE Inhibitors Product Offered

Table 168. Omeros Corporation PDE Inhibitors Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 169. Omeros Corporation Main Business

Table 170. Omeros Corporation Latest Developments

Table 171. Medimetriks Pharmaceuticals Basic Information, PDE Inhibitors Manufacturing Base, Sales Area and Its Competitors

Table 172. Medimetriks Pharmaceuticals PDE Inhibitors Product Offered

Table 173. Medimetriks Pharmaceuticals PDE Inhibitors Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 174. Medimetriks Pharmaceuticals Main Business

Table 175. Medimetriks Pharmaceuticals Latest Developments

Table 176. NuSirt Biopharma Basic Information, PDE Inhibitors Manufacturing Base, Sales Area and Its Competitors

Table 177. NuSirt Biopharma PDE Inhibitors Product Offered

Table 178. NuSirt Biopharma PDE Inhibitors Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 179. NuSirt Biopharma Main Business

Table 180. NuSirt Biopharma Latest Developments

Table 181. Palobiopharma Basic Information, PDE Inhibitors Manufacturing Base, Sales Area and Its Competitors

Table 182. Palobiopharma PDE Inhibitors Product Offered

Table 183. Palobiopharma PDE Inhibitors Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 184. Palobiopharma Main Business

Table 185. Palobiopharma Latest Developments

Table 186. Roivant Sciences Basic Information, PDE Inhibitors Manufacturing Base, Sales Area and Its Competitors

Table 187. Roivant Sciences PDE Inhibitors Product Offered

Table 188. Roivant Sciences PDE Inhibitors Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 189. Roivant Sciences Main Business

Table 190. Roivant Sciences Latest Developments

Table 191. Sagene Pharmaceuticals Basic Information, PDE Inhibitors Manufacturing Base, Sales Area and Its Competitors

Table 192. Sagene Pharmaceuticals PDE Inhibitors Product Offered

Table 193. Sagene Pharmaceuticals PDE Inhibitors Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 194. Sagene Pharmaceuticals Main Business

Table 195. Sagene Pharmaceuticals Latest Developments

Table 196. Tetra Discovery Partners Basic Information, PDE Inhibitors Manufacturing Base, Sales Area and Its Competitors

Table 197. Tetra Discovery Partners PDE Inhibitors Product Offered

Table 198. Tetra Discovery Partners PDE Inhibitors Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 199. Tetra Discovery Partners Main Business

Table 200. Tetra Discovery Partners Latest Developments

Table 201. Tritech Biopharm Basic Information, PDE Inhibitors Manufacturing Base, Sales Area and Its Competitors

Table 202. Tritech Biopharm PDE Inhibitors Product Offered

Table 203. Tritech Biopharm PDE Inhibitors Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 204. Tritech Biopharm Main Business

Table 205. Tritech Biopharm Latest Developments

Table 206. Otsuka Basic Information, PDE Inhibitors Manufacturing Base, Sales Area and Its Competitors

Table 207. Otsuka PDE Inhibitors Product Offered

Table 208. Otsuka PDE Inhibitors Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 209. Otsuka Main Business

Table 210. Otsuka Latest Developments

Table 211. Chiesi Farmaceutici Basic Information, PDE Inhibitors Manufacturing Base, Sales Area and Its Competitors

Table 212. Chiesi Farmaceutici PDE Inhibitors Product Offered

Table 213. Chiesi Farmaceutici PDE Inhibitors Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 214. Chiesi Farmaceutici Main Business

Table 215. Chiesi Farmaceutici Latest Developments

Table 216. Verona Pharma Basic Information, PDE Inhibitors Manufacturing Base, Sales Area and Its Competitors

Table 217. Verona Pharma PDE Inhibitors Product Offered

Table 218. Verona Pharma PDE Inhibitors Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 219. Verona Pharma Main Business

Table 220. Verona Pharma Latest Developments

List of Figures

Figure 1. Picture of PDE Inhibitors

Figure 2. PDE Inhibitors Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global PDE Inhibitors Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global PDE Inhibitors Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. PDE Inhibitors Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of PDE5

Figure 10. Product Picture of PDE4

Figure 11. Product Picture of Viagra

Figure 12. Product Picture of Cialis

Figure 13. Product Picture of Levitra

Figure 14. Product Picture of Others

Figure 15. Global PDE Inhibitors Sales Market Share by Type in 2021

Figure 16. Global PDE Inhibitors Revenue Market Share by Type (2017-2022)

Figure 17. PDE Inhibitors Consumed in Genitourinary

Figure 18. Global PDE Inhibitors Market: Genitourinary (2017-2022) & (K Units)

Figure 19. PDE Inhibitors Consumed in Cardiovascular Diseases

Figure 20. Global PDE Inhibitors Market: Cardiovascular Diseases (2017-2022) & (K Units)

Figure 21. PDE Inhibitors Consumed in Dermatological Disorders

Figure 22. Global PDE Inhibitors Market: Dermatological Disorders (2017-2022) & (K Units)

Figure 23. PDE Inhibitors Consumed in Respiratory Diseases

Figure 24. Global PDE Inhibitors Market: Respiratory Diseases (2017-2022) & (K Units)

Figure 25. PDE Inhibitors Consumed in Schizophrenia

Figure 26. Global PDE Inhibitors Market: Schizophrenia (2017-2022) & (K Units)

Figure 27. PDE Inhibitors Consumed in Alzheimer’S Disease

Figure 28. Global PDE Inhibitors Market: Alzheimer’S Disease (2017-2022) & (K Units)

Figure 29. PDE Inhibitors Consumed in Huntington’S Disease

Figure 30. Global PDE Inhibitors Market: Huntington’S Disease (2017-2022) & (K Units)

Figure 31. PDE Inhibitors Consumed in Others

Figure 32. Global PDE Inhibitors Market: Others (2017-2022) & (K Units)

Figure 33. Global PDE Inhibitors Sales Market Share by Application (2017-2022)

Figure 34. Global PDE Inhibitors Revenue Market Share by Application in 2021

Figure 35. PDE Inhibitors Revenue Market by Company in 2021 ($ Million)

Figure 36. Global PDE Inhibitors Revenue Market Share by Company in 2021

Figure 37. Global PDE Inhibitors Sales Market Share by Geographic Region (2017-2022)

Figure 38. Global PDE Inhibitors Revenue Market Share by Geographic Region in 2021

Figure 39. Global PDE Inhibitors Sales Market Share by Region (2017-2022)

Figure 40. Global PDE Inhibitors Revenue Market Share by Country/Region in 2021

Figure 41. Americas PDE Inhibitors Sales 2017-2022 (K Units)

Figure 42. Americas PDE Inhibitors Revenue 2017-2022 ($ Millions)

Figure 43. APAC PDE Inhibitors Sales 2017-2022 (K Units)

Figure 44. APAC PDE Inhibitors Revenue 2017-2022 ($ Millions)

Figure 45. Europe PDE Inhibitors Sales 2017-2022 (K Units)

Figure 46. Europe PDE Inhibitors Revenue 2017-2022 ($ Millions)

Figure 47. Middle East & Africa PDE Inhibitors Sales 2017-2022 (K Units)

Figure 48. Middle East & Africa PDE Inhibitors Revenue 2017-2022 ($ Millions)

Figure 49. Americas PDE Inhibitors Sales Market Share by Country in 2021

Figure 50. Americas PDE Inhibitors Revenue Market Share by Country in 2021

Figure 51. United States PDE Inhibitors Revenue Growth 2017-2022 ($ Millions)

Figure 52. Canada PDE Inhibitors Revenue Growth 2017-2022 ($ Millions)

Figure 53. Mexico PDE Inhibitors Revenue Growth 2017-2022 ($ Millions)

Figure 54. Brazil PDE Inhibitors Revenue Growth 2017-2022 ($ Millions)

Figure 55. APAC PDE Inhibitors Sales Market Share by Region in 2021

Figure 56. APAC PDE Inhibitors Revenue Market Share by Regions in 2021

Figure 57. China PDE Inhibitors Revenue Growth 2017-2022 ($ Millions)

Figure 58. Japan PDE Inhibitors Revenue Growth 2017-2022 ($ Millions)

Figure 59. South Korea PDE Inhibitors Revenue Growth 2017-2022 ($ Millions)

Figure 60. Southeast Asia PDE Inhibitors Revenue Growth 2017-2022 ($ Millions)

Figure 61. India PDE Inhibitors Revenue Growth 2017-2022 ($ Millions)

Figure 62. Australia PDE Inhibitors Revenue Growth 2017-2022 ($ Millions)

Figure 63. Europe PDE Inhibitors Sales Market Share by Country in 2021

Figure 64. Europe PDE Inhibitors Revenue Market Share by Country in 2021

Figure 65. Germany PDE Inhibitors Revenue Growth 2017-2022 ($ Millions)

Figure 66. France PDE Inhibitors Revenue Growth 2017-2022 ($ Millions)

Figure 67. UK PDE Inhibitors Revenue Growth 2017-2022 ($ Millions)

Figure 68. Italy PDE Inhibitors Revenue Growth 2017-2022 ($ Millions)

Figure 69. Russia PDE Inhibitors Revenue Growth 2017-2022 ($ Millions)

Figure 70. Middle East & Africa PDE Inhibitors Sales Market Share by Country in 2021

Figure 71. Middle East & Africa PDE Inhibitors Revenue Market Share by Country in 2021

Figure 72. Egypt PDE Inhibitors Revenue Growth 2017-2022 ($ Millions)

Figure 73. South Africa PDE Inhibitors Revenue Growth 2017-2022 ($ Millions)

Figure 74. Israel PDE Inhibitors Revenue Growth 2017-2022 ($ Millions)

Figure 75. Turkey PDE Inhibitors Revenue Growth 2017-2022 ($ Millions)

Figure 76. GCC Country PDE Inhibitors Revenue Growth 2017-2022 ($ Millions)

Figure 77. Manufacturing Cost Structure Analysis of PDE Inhibitors in 2021

Figure 78. Manufacturing Process Analysis of PDE Inhibitors

Figure 79. Industry Chain Structure of PDE Inhibitors

Figure 80. Channels of Distribution

Figure 81. Distributors Profiles